M&T Bank Corp Buys Shares of 7,940 Qiagen N.V. (QGEN)

M&T Bank Corp bought a new stake in Qiagen N.V. (NASDAQ:QGEN) during the first quarter, Holdings Channel reports. The firm bought 7,940 shares of the company’s stock, valued at approximately $230,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Wetherby Asset Management Inc. raised its position in shares of Qiagen N.V. by 1.8% in the first quarter. Wetherby Asset Management Inc. now owns 9,273 shares of the company’s stock worth $269,000 after buying an additional 163 shares in the last quarter. Private Advisor Group LLC raised its position in shares of Qiagen N.V. by 2.8% in the fourth quarter. Private Advisor Group LLC now owns 9,431 shares of the company’s stock worth $264,000 after buying an additional 258 shares in the last quarter. Opus Point Partners Management LLC raised its position in shares of Qiagen N.V. by 1.0% in the fourth quarter. Opus Point Partners Management LLC now owns 111,683 shares of the company’s stock worth $3,129,000 after buying an additional 1,118 shares in the last quarter. Public Sector Pension Investment Board raised its position in shares of Qiagen N.V. by 4.2% in the fourth quarter. Public Sector Pension Investment Board now owns 45,496 shares of the company’s stock worth $1,280,000 after buying an additional 1,851 shares in the last quarter. Finally, Parametrica Management Ltd raised its position in shares of Qiagen N.V. by 38.7% in the first quarter. Parametrica Management Ltd now owns 10,107 shares of the company’s stock worth $293,000 after buying an additional 2,818 shares in the last quarter. 61.04% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Qiagen N.V. (NASDAQ:QGEN)

Shares of Qiagen N.V. (NASDAQ:QGEN) opened at 34.61 on Tuesday. The firm has a 50 day moving average price of $32.93 and a 200-day moving average price of $30.00. The company has a market cap of $7.88 billion, a P/E ratio of 96.14 and a beta of 1.15. Qiagen N.V. has a 12 month low of $20.71 and a 12 month high of $35.01.

COPYRIGHT VIOLATION NOTICE: “M&T Bank Corp Buys Shares of 7,940 Qiagen N.V. (QGEN)” was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://www.tickerreport.com/banking-finance/2654972/mt-bank-corp-buys-shares-of-7940-qiagen-n-v-qgen.html.

A number of research analysts have recently commented on the company. TheStreet raised Qiagen N.V. from a “c” rating to a “b” rating in a report on Monday, June 5th. Commerzbank Ag restated a “buy” rating on shares of Qiagen N.V. in a research note on Monday, May 29th. DZ Bank AG restated a “neutral” rating on shares of Qiagen N.V. in a research note on Monday, May 29th. BidaskClub downgraded Qiagen N.V. from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 10th. Finally, Zacks Investment Research upgraded Qiagen N.V. from a “sell” rating to a “hold” rating in a research note on Friday, April 21st. Seven analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $28.36.

Qiagen N.V. Company Profile

QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:QGEN”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Want to see what other hedge funds are holding QGEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Qiagen N.V. (NASDAQ:QGEN).

Receive News & Ratings for Qiagen N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qiagen N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
Shares at Radius Jump as Bone Drug of Amgen Has Setback
Shares at Radius Jump as Bone Drug of Amgen Has Setback


© 2006-2017 Ticker Report. Google+.